AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] The Scotts Miracle-Gro Company Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Scotts Miracle-Gro (SMG) Form 4 highlights: On 08/04/2025 the Hagedorn Partnership, L.P.—a 10% owner whose general partners include Chairman & CEO James Hagedorn—executed two open-market sales of common shares.

  • 38,314 shares sold at a weighted-average $62.14
  • 31,686 shares sold at a weighted-average $62.45

Aggregate disposition of �70,000 shares generated roughly $4.4 million in proceeds. After the transactions, the Partnership’s direct stake decreased from 13,345,960 to 13,274,274 shares, a reduction of about 0.5%. No derivative securities were traded, and the insiders continue to control more than 13 million shares through various direct and indirect holdings (401(k), individual accounts, and executive ownership).

The filing, signed 08/06/2025, involves multiple reporting persons (James, Katherine, Robert & Susan Hagedorn and EVP/COO Nathan Baxter). Each disclaims beneficial ownership beyond their economic interest. There is no indication the sales were made under a Rule 10b5-1 plan. While the dollar amount is modest relative to the group’s position, the activity represents the first reported sale since prior filings and may be viewed as a modestly negative sentiment signal.

Riepilogo del Modulo 4 di Scotts Miracle-Gro (SMG): L'08/04/2025, la Hagedorn Partnership, L.P.—un azionista con il 10% di partecipazione i cui soci accomandatari includono il Presidente e CEO James Hagedorn—ha effettuato due vendite sul mercato aperto di azioni ordinarie.

  • 38.314 azioni vendute a un prezzo medio ponderato di 62,14 $
  • 31.686 azioni vendute a un prezzo medio ponderato di 62,45 $

La cessione complessiva di circa 70.000 azioni ha generato circa 4,4 milioni di dollari di ricavi. Dopo le transazioni, la partecipazione diretta della Partnership è scesa da 13.345.960 a 13.274.274 azioni, una riduzione di circa il 0,5%. Non sono stati scambiati titoli derivati e gli insider continuano a detenere oltre 13 milioni di azioni attraverso varie partecipazioni dirette e indirette (401(k), conti individuali e proprietà esecutiva).

Il documento, firmato il 06/08/2025, coinvolge più soggetti segnalanti (James, Katherine, Robert e Susan Hagedorn e il EVP/COO Nathan Baxter). Ognuno nega la titolarità beneficiaria oltre il proprio interesse economico. Non vi è alcuna indicazione che le vendite siano state effettuate nell’ambito di un piano Rule 10b5-1. Sebbene l’importo in dollari sia modesto rispetto alla posizione del gruppo, l’attività rappresenta la prima vendita segnalata dopo precedenti comunicazioni e potrebbe essere interpretata come un segnale di sentiment leggermente negativo.

Aspectos destacados del Formulario 4 de Scotts Miracle-Gro (SMG): El 04/08/2025, la Hagedorn Partnership, L.P.—un propietario del 10% cuyos socios generales incluyen al Presidente y CEO James Hagedorn—realizó dos ventas en el mercado abierto de acciones comunes.

  • 38,314 acciones vendidas a un precio promedio ponderado de 62,14 $
  • 31,686 acciones vendidas a un precio promedio ponderado de 62,45 $

La disposición agregada de aproximadamente 70,000 acciones generó alrededor de 4.4 millones de dólares en ingresos. Tras las transacciones, la participación directa de la sociedad disminuyó de 13,345,960 a 13,274,274 acciones, una reducción de aproximadamente el 0.5%. No se negociaron valores derivados y los insiders continúan controlando más de 13 millones de acciones a través de diversas participaciones directas e indirectas (401(k), cuentas individuales y propiedad ejecutiva).

El informe, firmado el 06/08/2025, involucra a múltiples personas que reportan (James, Katherine, Robert y Susan Hagedorn y el EVP/COO Nathan Baxter). Cada uno niega la propiedad beneficiaria más allá de su interés económico. No hay indicios de que las ventas se hayan realizado bajo un plan Rule 10b5-1. Aunque el monto en dólares es modesto en relación con la posición del grupo, la actividad representa la primera venta reportada desde informes anteriores y puede considerarse una señal de sentimiento ligeramente negativa.

Scotts Miracle-Gro (SMG) Form 4 주요 ë‚´ìš©: 2025ë…� 8ì›� 4ì�, Hagedorn Partnership, L.P.—회ìž� ê²� CEOì� James Hagedornì� í¬í•¨ë� ì¼ë°˜ 파트너가 10% ì§€ë¶„ì„ ë³´ìœ í•� 회사—가 보통주를 ë‘� 차례 공개 시장ì—서 매ë„하였습니ë‹�.

  • 38,314주를 ê°€ì¤� í‰ê·  $62.14ì—� 매ë„
  • 31,686주를 ê°€ì¤� í‰ê·  $62.45ì—� 매ë„

ì´� ì•� 70,000ì£� 매ë„ë¡� ì•� 440ë§� 달러ì� 수ìµì� 창출했습니다. 거래 í›� 파트너십ì� ì§ì ‘ ì§€ë¶„ì€ 13,345,960주ì—ì„� 13,274,274ì£�ë¡� ì•� 0.5% ê°ì†Œí–ˆìŠµë‹ˆë‹¤. íŒŒìƒ ì¦ê¶Œ 거래ëŠ� 없었으며, ë‚´ë¶€ìžë“¤ì€ 401(k), ê°œì¸ ê³„ì¢Œ, ê²½ì˜ì§� 소유 ë“� 다양í•� ì§ì ‘ ë°� ê°„ì ‘ 보유ë¥� 통해 1,300ë§� ì£� ì´ìƒì� ê³„ì† ë³´ìœ í•˜ê³  있습니다.

2025ë…� 8ì›� 6ì� 서명ë� 신고서ì—ëŠ� 여러 ë³´ê³ ìžê°€ í¬í•¨ë˜ì–´ 있습니다(James, Katherine, Robert & Susan Hagedorn ë°� EVP/COO Nathan Baxter). ê°ìžëŠ� 경제ì � ì´ìµì� 초과하는 실질 ì†Œìœ ê¶Œì„ ë¶€ì¸í•©ë‹ˆë‹¤. ì� 매ë„ë“¤ì´ Rule 10b5-1 계íšì—� ë”°ë¼ ì´ë£¨ì–´ì¡Œë‹¤ëŠ” 징후ëŠ� 없습니다. ê¸ˆì•¡ì€ ê·¸ë£¹ì� ì§€ë¶„ì— ë¹„í•´ ì ì€ 편ì´ì§€ë§�, ì´ë²ˆ 활ë™ì€ ì´ì „ ì‹ ê³  ì´í›„ ì²� 매ë„ì´ë©° 다소 부정ì ì� 심리 신호ë¡� í•´ì„ë� ìˆ� 있습니다.

Points clés du Formulaire 4 de Scotts Miracle-Gro (SMG) : Le 04/08/2025, la Hagedorn Partnership, L.P.—un détenteur de 10 % dont les associés commandités incluent le Président-directeur général James Hagedorn—a effectué deux ventes d’actions ordinaires sur le marché ouvert.

  • 38 314 actions vendues à un prix moyen pondéré de 62,14 $
  • 31 686 actions vendues à un prix moyen pondéré de 62,45 $

La cession globale d’environ 70 000 actions a généré environ 4,4 millions de dollars de recettes. Après ces transactions, la participation directe de la Partnership est passée de 13 345 960 à 13 274 274 actions, soit une réduction d’environ 0,5 %. Aucun titre dérivé n’a été négocié, et les initiés continuent de contrôler plus de 13 millions d’actions via diverses participations directes et indirectes (401(k), comptes individuels et propriété exécutive).

Le dépôt, signé le 06/08/2025, concerne plusieurs personnes déclarantes (James, Katherine, Robert & Susan Hagedorn ainsi que le EVP/COO Nathan Baxter). Chacun nie la propriété bénéficiaire au-delà de son intérêt économique. Il n’y a aucune indication que les ventes aient été réalisées dans le cadre d’un plan Rule 10b5-1. Bien que le montant en dollars soit modeste par rapport à la position du groupe, cette activité représente la première vente signalée depuis les déclarations précédentes et peut être perçue comme un signe de sentiment légèrement négatif.

Höhepunkte des Form 4 von Scotts Miracle-Gro (SMG): Am 04.08.2025 führte die Hagedorn Partnership, L.P.—ein 10%-Eigentümer, dessen Komplementäre unter anderem Vorsitzender und CEO James Hagedorn sind—zwei Verkäufe von Stammaktien am offenen Markt durch.

  • 38.314 Aktien zu einem gewichteten Durchschnittspreis von 62,14 $ verkauft
  • 31.686 Aktien zu einem gewichteten Durchschnittspreis von 62,45 $ verkauft

Die Gesamtveräußerung von etwa 70.000 Aktien brachte rund 4,4 Millionen Dollar Erlös ein. Nach den Transaktionen sank der direkte Anteil der Partnerschaft von 13.345.960 auf 13.274.274 Aktien, eine Reduzierung um etwa 0,5%. Es wurden keine Derivate gehandelt, und die Insider kontrollieren weiterhin über 13 Millionen Aktien durch verschiedene direkte und indirekte Beteiligungen (401(k), Einzelkonten und Geschäftsführereigentum).

Die Einreichung, unterzeichnet am 06.08.2025, betrifft mehrere meldepflichtige Personen (James, Katherine, Robert & Susan Hagedorn sowie EVP/COO Nathan Baxter). Jeder weist eine wirtschaftliche Eigentümerschaft über sein wirtschaftliches Interesse hinaus zurück. Es gibt keine Hinweise darauf, dass die Verkäufe im Rahmen eines Rule 10b5-1-Plans erfolgt sind. Obwohl der Dollarbetrag im Verhältnis zur Position der Gruppe bescheiden ist, stellt die Aktivität den ersten gemeldeten Verkauf seit früheren Meldungen dar und könnte als leicht negatives Stimmungssignal gewertet werden.

Positive
  • Insiders retain a very large stake of over 13.27 million shares, signalling continued long-term alignment with shareholders.
Negative
  • Approx. 70,000 shares sold by 10% owner may be interpreted as reduced confidence or portfolio diversification.
  • No disclosure that sales were executed under a Rule 10b5-1 trading plan, increasing perceived discretion of the transactions.

Insights

TL;DR: Controlling Hagedorn group sold 0.5% of stake; signal mildly negative but ownership remains heavy.

The Partnership’s sale of ~70 k shares at ~US$62 trims only a sliver of its 13.3 m-share holding, so dilution impact is negligible. However, investors often treat sales by founder/insiders—especially when no 10b5-1 plan is cited—as a sentiment headwind. The proceeds (<4.5 m) are immaterial to SMG’s daily dollar volume, so technical pressure should be limited. The continued >13 m-share position (roughly 24 % of outstanding, based on last 10-Q) shows alignment remains high. Absent larger follow-on sales or an explanatory note (tax, diversification), this event is best viewed as a slight negative datapoint rather than a thesis-changing move.

Riepilogo del Modulo 4 di Scotts Miracle-Gro (SMG): L'08/04/2025, la Hagedorn Partnership, L.P.—un azionista con il 10% di partecipazione i cui soci accomandatari includono il Presidente e CEO James Hagedorn—ha effettuato due vendite sul mercato aperto di azioni ordinarie.

  • 38.314 azioni vendute a un prezzo medio ponderato di 62,14 $
  • 31.686 azioni vendute a un prezzo medio ponderato di 62,45 $

La cessione complessiva di circa 70.000 azioni ha generato circa 4,4 milioni di dollari di ricavi. Dopo le transazioni, la partecipazione diretta della Partnership è scesa da 13.345.960 a 13.274.274 azioni, una riduzione di circa il 0,5%. Non sono stati scambiati titoli derivati e gli insider continuano a detenere oltre 13 milioni di azioni attraverso varie partecipazioni dirette e indirette (401(k), conti individuali e proprietà esecutiva).

Il documento, firmato il 06/08/2025, coinvolge più soggetti segnalanti (James, Katherine, Robert e Susan Hagedorn e il EVP/COO Nathan Baxter). Ognuno nega la titolarità beneficiaria oltre il proprio interesse economico. Non vi è alcuna indicazione che le vendite siano state effettuate nell’ambito di un piano Rule 10b5-1. Sebbene l’importo in dollari sia modesto rispetto alla posizione del gruppo, l’attività rappresenta la prima vendita segnalata dopo precedenti comunicazioni e potrebbe essere interpretata come un segnale di sentiment leggermente negativo.

Aspectos destacados del Formulario 4 de Scotts Miracle-Gro (SMG): El 04/08/2025, la Hagedorn Partnership, L.P.—un propietario del 10% cuyos socios generales incluyen al Presidente y CEO James Hagedorn—realizó dos ventas en el mercado abierto de acciones comunes.

  • 38,314 acciones vendidas a un precio promedio ponderado de 62,14 $
  • 31,686 acciones vendidas a un precio promedio ponderado de 62,45 $

La disposición agregada de aproximadamente 70,000 acciones generó alrededor de 4.4 millones de dólares en ingresos. Tras las transacciones, la participación directa de la sociedad disminuyó de 13,345,960 a 13,274,274 acciones, una reducción de aproximadamente el 0.5%. No se negociaron valores derivados y los insiders continúan controlando más de 13 millones de acciones a través de diversas participaciones directas e indirectas (401(k), cuentas individuales y propiedad ejecutiva).

El informe, firmado el 06/08/2025, involucra a múltiples personas que reportan (James, Katherine, Robert y Susan Hagedorn y el EVP/COO Nathan Baxter). Cada uno niega la propiedad beneficiaria más allá de su interés económico. No hay indicios de que las ventas se hayan realizado bajo un plan Rule 10b5-1. Aunque el monto en dólares es modesto en relación con la posición del grupo, la actividad representa la primera venta reportada desde informes anteriores y puede considerarse una señal de sentimiento ligeramente negativa.

Scotts Miracle-Gro (SMG) Form 4 주요 ë‚´ìš©: 2025ë…� 8ì›� 4ì�, Hagedorn Partnership, L.P.—회ìž� ê²� CEOì� James Hagedornì� í¬í•¨ë� ì¼ë°˜ 파트너가 10% ì§€ë¶„ì„ ë³´ìœ í•� 회사—가 보통주를 ë‘� 차례 공개 시장ì—서 매ë„하였습니ë‹�.

  • 38,314주를 ê°€ì¤� í‰ê·  $62.14ì—� 매ë„
  • 31,686주를 ê°€ì¤� í‰ê·  $62.45ì—� 매ë„

ì´� ì•� 70,000ì£� 매ë„ë¡� ì•� 440ë§� 달러ì� 수ìµì� 창출했습니다. 거래 í›� 파트너십ì� ì§ì ‘ ì§€ë¶„ì€ 13,345,960주ì—ì„� 13,274,274ì£�ë¡� ì•� 0.5% ê°ì†Œí–ˆìŠµë‹ˆë‹¤. íŒŒìƒ ì¦ê¶Œ 거래ëŠ� 없었으며, ë‚´ë¶€ìžë“¤ì€ 401(k), ê°œì¸ ê³„ì¢Œ, ê²½ì˜ì§� 소유 ë“� 다양í•� ì§ì ‘ ë°� ê°„ì ‘ 보유ë¥� 통해 1,300ë§� ì£� ì´ìƒì� ê³„ì† ë³´ìœ í•˜ê³  있습니다.

2025ë…� 8ì›� 6ì� 서명ë� 신고서ì—ëŠ� 여러 ë³´ê³ ìžê°€ í¬í•¨ë˜ì–´ 있습니다(James, Katherine, Robert & Susan Hagedorn ë°� EVP/COO Nathan Baxter). ê°ìžëŠ� 경제ì � ì´ìµì� 초과하는 실질 ì†Œìœ ê¶Œì„ ë¶€ì¸í•©ë‹ˆë‹¤. ì� 매ë„ë“¤ì´ Rule 10b5-1 계íšì—� ë”°ë¼ ì´ë£¨ì–´ì¡Œë‹¤ëŠ” 징후ëŠ� 없습니다. ê¸ˆì•¡ì€ ê·¸ë£¹ì� ì§€ë¶„ì— ë¹„í•´ ì ì€ 편ì´ì§€ë§�, ì´ë²ˆ 활ë™ì€ ì´ì „ ì‹ ê³  ì´í›„ ì²� 매ë„ì´ë©° 다소 부정ì ì� 심리 신호ë¡� í•´ì„ë� ìˆ� 있습니다.

Points clés du Formulaire 4 de Scotts Miracle-Gro (SMG) : Le 04/08/2025, la Hagedorn Partnership, L.P.—un détenteur de 10 % dont les associés commandités incluent le Président-directeur général James Hagedorn—a effectué deux ventes d’actions ordinaires sur le marché ouvert.

  • 38 314 actions vendues à un prix moyen pondéré de 62,14 $
  • 31 686 actions vendues à un prix moyen pondéré de 62,45 $

La cession globale d’environ 70 000 actions a généré environ 4,4 millions de dollars de recettes. Après ces transactions, la participation directe de la Partnership est passée de 13 345 960 à 13 274 274 actions, soit une réduction d’environ 0,5 %. Aucun titre dérivé n’a été négocié, et les initiés continuent de contrôler plus de 13 millions d’actions via diverses participations directes et indirectes (401(k), comptes individuels et propriété exécutive).

Le dépôt, signé le 06/08/2025, concerne plusieurs personnes déclarantes (James, Katherine, Robert & Susan Hagedorn ainsi que le EVP/COO Nathan Baxter). Chacun nie la propriété bénéficiaire au-delà de son intérêt économique. Il n’y a aucune indication que les ventes aient été réalisées dans le cadre d’un plan Rule 10b5-1. Bien que le montant en dollars soit modeste par rapport à la position du groupe, cette activité représente la première vente signalée depuis les déclarations précédentes et peut être perçue comme un signe de sentiment légèrement négatif.

Höhepunkte des Form 4 von Scotts Miracle-Gro (SMG): Am 04.08.2025 führte die Hagedorn Partnership, L.P.—ein 10%-Eigentümer, dessen Komplementäre unter anderem Vorsitzender und CEO James Hagedorn sind—zwei Verkäufe von Stammaktien am offenen Markt durch.

  • 38.314 Aktien zu einem gewichteten Durchschnittspreis von 62,14 $ verkauft
  • 31.686 Aktien zu einem gewichteten Durchschnittspreis von 62,45 $ verkauft

Die Gesamtveräußerung von etwa 70.000 Aktien brachte rund 4,4 Millionen Dollar Erlös ein. Nach den Transaktionen sank der direkte Anteil der Partnerschaft von 13.345.960 auf 13.274.274 Aktien, eine Reduzierung um etwa 0,5%. Es wurden keine Derivate gehandelt, und die Insider kontrollieren weiterhin über 13 Millionen Aktien durch verschiedene direkte und indirekte Beteiligungen (401(k), Einzelkonten und Geschäftsführereigentum).

Die Einreichung, unterzeichnet am 06.08.2025, betrifft mehrere meldepflichtige Personen (James, Katherine, Robert & Susan Hagedorn sowie EVP/COO Nathan Baxter). Jeder weist eine wirtschaftliche Eigentümerschaft über sein wirtschaftliches Interesse hinaus zurück. Es gibt keine Hinweise darauf, dass die Verkäufe im Rahmen eines Rule 10b5-1-Plans erfolgt sind. Obwohl der Dollarbetrag im Verhältnis zur Position der Gruppe bescheiden ist, stellt die Aktivität den ersten gemeldeten Verkauf seit früheren Meldungen dar und könnte als leicht negatives Stimmungssignal gewertet werden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hagedorn Partnership, L.P.

(Last) (First) (Middle)
800 PORT WASHINGTON BOULEVARD

(Street)
PORT WASHINGTON NY 11050

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SCOTTS MIRACLE-GRO CO [ SMG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 08/04/2025 S 38,314 D $62.14(1) 13,305,960 D(3)
Common Shares 08/04/2025 S 31,686 D $62.45(2) 13,274,274 D(3)
Common Shares 79,694.1493 I See footnote(4)
Common Shares 29,413.378 I See footnote(5)
Common Shares 6,940 I See footnote(6)
Common Shares 50,602.6841 I See footnote(7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Hagedorn Partnership, L.P.

(Last) (First) (Middle)
800 PORT WASHINGTON BOULEVARD

(Street)
PORT WASHINGTON NY 11050

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
HAGEDORN JAMES

(Last) (First) (Middle)
C/O HAGEDORN PARTNERSHIP, L.P.
800 PORT WASHINGTON BOULEVARD

(Street)
PORT WASHINGTON NY 11050

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chairman, CEO and President
1. Name and Address of Reporting Person*
HAGEDORN KATHERINE LITTLEFIELD

(Last) (First) (Middle)
C/O HAGEDORN PARTNERSHIP, L.P.
800 PORT WASHINGTON BOULEVARD

(Street)
PORT WASHINGTON NY 11050

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
HAGEDORN ROBERT

(Last) (First) (Middle)
C/O HAGEDORN PARTNERSHIP, L.P.
800 PORT WASHINGTON BOULEVARD

(Street)
PORT WASHINGTON NY 11050

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
HAGEDORN SUSAN

(Last) (First) (Middle)
C/O HAGEDORN PARTNERSHIP, L.P.
800 PORT WASHINGTON BOULEVARD

(Street)
PORT WASHINGTON NY 11050

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Baxter Nathan Eric

(Last) (First) (Middle)
C/O HAGEDORN PARTNERSHIP, L.P.
800 PORT WASHINGTON BOULEVARD

(Street)
PORT WASHINGTON NY 11050

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
X Officer (give title below) Other (specify below)
EVP and COO
Explanation of Responses:
1. The transaction was executed in multiple trades at prices ranging from $61.28 to $62.27 The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
2. The transaction was executed in multiple trades at prices ranging from $62.28 to $62.61 The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
3. Held by the Hagedorn Partnership, L.P. (the "Hagedorn Partnership"). James Hagedorn, Katherine Hagedorn Littlefield, Peter Hagedorn, Robert Hagedorn, and Susan Hagedorn are the general partners of the Hagedorn Partnership. Each of the general partners disclaim beneficial ownership of the reported securities, except to the extent of their pecuniary interest therein.
4. Held directly by James Hagedorn.
5. Held indirectly by a 401(K) plan for James Hagedorn. Mr. Hagedorn is Chairman, Chief Executive Officer and President of the Issuer.
6. Held directly by Katherine Hagedorn Littlefield.
7. Held directly by Nathan Baxter. Mr. Baxter is Executive Vice President and Chief Operating Officer of the Issuer.
/s/ Rob McMahon - Attorney-in-Fact for Hagedorn Partnership, L.P. 08/06/2025
/s/ Rob McMahon - Attorney-in-Fact for James Hagedorn 08/06/2025
/s/ Rob McMahon - Attorney-in-Fact for Katherine Hagedorn Littlefield 08/06/2025
/s/ Rob McMahon - Attorney-in-Fact for Robert Hagedorn 08/06/2025
/s/ Rob McMahon - Attorney-in-Fact for Susan Hagedorn 08/06/2025
/s/ Rob McMahon - Attorney-in-Fact for Nathan Baxter 08/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many SMG shares did the Hagedorn Partnership sell on 08/04/2025?

The partnership sold a total of 69,,,999 shares (38,314 + 31,686).

At what price were the Scotts Miracle-Gro shares sold?

Weighted-average prices were $62.14 and $62.45, with individual trade prices ranging from $61.28 to $62.61.

How many SMG shares does the Hagedorn group still own after the sale?

Following the transactions they directly hold 13,274,274 common shares, plus additional indirect holdings disclosed in the filing.

Were any derivative securities traded in this Form 4?

No. Table II is blank; the filing reports only open-market sales of common shares.

Does the filing mention a Rule 10b5-1 trading plan?

The form contains the 10b5-1 checkbox but does not indicate that these transactions were made under such a plan.
Scotts Miracle Gr

NYSE:SMG

SMG Rankings

SMG Latest News

SMG Latest SEC Filings

SMG Stock Data

3.54B
43.83M
24.09%
74.6%
7.27%
Agricultural Inputs
Agricultural Chemicals
United States
MARYSVILLE